|Application ||WB, E|
|Other Accession||P62255, P62254, Q4R5Y8, NP_003333.1|
|Predicted||Monkey, Mouse, Rat|
|Calculated MW||19509 Da|
|Antigen Region||127-155 aa|
|Other Names||Ubiquitin-conjugating enzyme E2 G1, E217K, UBC7, Ubiquitin carrier protein G1, Ubiquitin-protein ligase G1, Ubiquitin-conjugating enzyme E2 G1, N-terminally processed, UBE2G1, UBE2G|
|Target/Specificity||This UBE2G1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 127-155 amino acids from the C-terminal region of human UBE2G1.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||UBE2G1 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys- 48'-, as well as 'Lys-63'-linked polyubiquitination. May be involved in degradation of muscle-specific proteins. Mediates polyubiquitination of CYP3A4.|
|Tissue Location||Widely expressed, mainly in skeletal muscle.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family and catalyzes the covalent attachment of ubiquitin to other proteins. The protein may be involved in degradation of muscle-specific proteins. [provided by RefSeq].
Hassink, G., et al. Biochem. J. 388 (PT 2), 647-655 (2005) :
Kim, B.W., et al. Mol. Endocrinol. 17(12):2603-2612(2003)
Gevaert, K., et al. Nat. Biotechnol. 21(5):566-569(2003)
Imai, Y., et al. Cell 105(7):891-902(2001)
Tiwari, S., et al. J. Biol. Chem. 276(19):16193-16200(2001)
If you have any additional inquiries please email technical services at email@example.com.